GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » Total Debt per Share

Chordia Therapeutics (TSE:190A) Total Debt per Share : 円0.00 (As of Aug. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Chordia Therapeutics Total Debt per Share?

円0.00 (As of Aug. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Chordia Therapeutics's Total Debt Per Share for the quarter that ended in Aug. 2024 was 円0.00.


Chordia Therapeutics Total Debt per Share Historical Data

The historical data trend for Chordia Therapeutics's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordia Therapeutics Total Debt per Share Chart

Chordia Therapeutics Annual Data
Trend Aug21 Aug22 Aug23 Aug24
Total Debt per Share
- - - -

Chordia Therapeutics Semi-Annual Data
Aug21 Aug22 Aug23 Aug24
Total Debt per Share - - - -

Chordia Therapeutics Total Debt per Share Calculation

Chordia Therapeutics's Total Debt Per Share for the fiscal year that ended in Aug. 2024 is calculated as:

Chordia Therapeutics's Total Debt Per Share for the quarter that ended in Aug. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chordia Therapeutics Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Chordia Therapeutics's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Chordia Therapeutics Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.

Chordia Therapeutics Headlines

No Headlines